Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation

被引:28
|
作者
Seo, Ji-Weon [1 ]
Kim, Hyun Kyung [1 ,2 ]
Kim, Ji-Eun [1 ,2 ]
Park, Seonyang [3 ]
Cho, Han-Ik [1 ]
机构
[1] Seoul Natl Univ, Dept Lab Med, Coll Med, Seoul 110744, South Korea
[2] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul 110744, South Korea
[3] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul 110744, South Korea
关键词
Disseminated intravascular coagulation; Procoagulant phospholipids; Factor Xa-activated clotting time; Thrombin-antithrombin complex; Endogenous thrombin potential; CRITICALLY-ILL PATIENTS; PLATELET MICROPARTICLES; SCORING SYSTEM; INTERNATIONAL SOCIETY; HEMOSTASIS; GENERATION; DIAGNOSIS; SEPSIS; PLASMA; RATIO;
D O I
10.1016/j.thromres.2008.03.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Widespread coagulation activation and intravascular fibrin formation are clinical features of disseminated intravascular coagulation (DIC). The endogenous thrombin potential (ETP) has been shown to be a useful marker for hypo- or hypercoagulability. The factor Xa-activated clotting time (XACT) represents plasma levels of procoagulant phospholipids. We investigated whether the ETP and XACT would be good prognostic markers in patients suspected of having DIC and whether these markers would show a significant correlation with the thrombin-antithrombin complex (TAT), a marker of in vivo coagulation activation. Methods: One hundred twenty-nine patients suspected of having DIC were enrolled for the study. The TAT was measured by ELISA. The ETP and XACT were measured by calibrated automated thrombinography. The 28-day mortality was used as a predictor of clinical outcomes. Results: In overt DIC, higher XACT (9.67 vs. 7.33 min) and higher TAT (26.15 vs. 11.56 ng/ml) results were obtained from the nonsurvivors than from the survivors.ETP levels were tower in the overt DIC group than in the no overt DIC group. In receiver operating characteristic analysis, which was conducted to predict the 28-day mortality, the areas under the receiver operating characteristic analysis curve were as follows: 0.71 (95% CI: 0.62-0.78) for the XACT, 0.70 (0.61-0.77) for the TAT, and 0.64 (0.55-0.72) for the ETP. For the diagnosis of overt DIC, the area under the curve of XACT, TAT and ETP were 0.77 (0.69-0.84), 0.64 (0.55-0.72) and 0.73 (0.64-0.80), respectively. The odds ratio of the XACT for the relative risk of 28-day mortality was 9.60 (3.53-26.11), and that of the TAT was 5.18 (2.11-12.72) and that of the ETP 7.66 (1.67-35.17). For the diagnosis of overt DIC, the odds ratio of XACT, TAT and ETP were 37.35 (4.86-286.89), 4.89 (1.93-12.43) and 4.89 (1.98-12.09), respectively. There was a negative correlation between the TAT and ETP (r=-0.223, P=0.012) and a positive correlation between the TAT and XACT (r=0.251, P=0.004). Conclusion: Our results suggest that the XACT and ETP may be useful diagnostic and prognostic markers for the DIC. Among various markers, the XACT serves as a good prediction of the 28-day mortality in patients suspected of having DIC. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:565 / 572
页数:8
相关论文
共 37 条
  • [21] Dual inhibition of thrombin and activated factor X attenuates disseminated intravascular coagulation and protects organ function in a baboon model of severe Gram-negative sepsis
    Schoechl, Herbert
    van Griensven, Martijn
    Heitmeier, Stefan
    Laux, Volker
    Kipman, Ulrike
    Roodt, Jan
    Bahrami, Soheyl
    Redl, Heinz
    CRITICAL CARE, 2017, 21
  • [22] Dual inhibition of thrombin and activated factor X attenuates disseminated intravascular coagulation and protects organ function in a baboon model of severe Gram-negative sepsis
    Herbert Schöchl
    Martijn van Griensven
    Stefan Heitmeier
    Volker Laux
    Ulrike Kipman
    Jan Roodt
    Soheyl Bahrami
    Heinz Redl
    Critical Care, 21
  • [23] Thrombus precursor protein, endogenous thrombin potential, von-Willebrand factor and activated factor VII in suspected deep vein thrombosis: is there a place for new parameters?
    Bucek, RA
    Reiter, M
    Quehenberger, P
    Weltermann, A
    Kyrle, PA
    Minar, E
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (01) : 123 - 128
  • [24] PLASMA PREKALLIKREIN(PPK), FACTOR-XII(F-XII), ANTITHROMBINIII(ATIII) IN INTENSIVE-CARE PATIENTS WITH SUSPECTED DISSEMINATED INTRAVASCULAR COAGULATION
    LAMMLE, B
    TRAN, TH
    DUCKERT, F
    THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 290 - 290
  • [25] Correlation Between, Anti-Factor Xa, Activated Partial. Thromboplastin Time, Activated Clotting Time, and R Time in Patients Supported With Continuous-Flow Left Ventricular Assist Devices
    Taimeh, Ziad
    Roy, Samit
    Fitzpatrick, Megan
    Pritzker, Marc
    Eckman, Peter
    John, Ranjit
    Colvin, Monica
    Thenappan, Thenappan
    Uriel, Nir
    Adatya, Sirtaz
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (08) : S116 - S116
  • [26] ANTITHROMBIN-III AND ANTI-ACTIVATED FACTOR-X ACTIVITY IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA AND DISSEMINATED INTRAVASCULAR COAGULATION TREATED WITH HEPARIN
    SANDLER, RM
    LIEBMAN, HA
    PATCH, MJ
    TEITELBAUM, A
    LEVINE, AM
    FEINSTEIN, DI
    CANCER, 1982, 50 (10) : 2106 - 2110
  • [27] A Normal Prothrombin Time, Activated Partial Thromboplastin Time and Fibrinogen Level Do Not Eliminate Disseminated Intravascular Coagulation (DIC) and Bleeding Risk in Patients with Acute Promyelocytic Leukemia
    Simon, Kathryn Sarah
    Kharkhanis, Prachi
    Caprara, Catherine R.
    Debragga, Stephanie
    Bolds, Sheldon
    Alghsoon, Saleh
    Arellano, Martha L.
    Kolhe, Ravindra
    Jillella, Anand
    Kota, Vamsi
    BLOOD, 2017, 130
  • [28] Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit
    Dempfle, CEH
    Lorenz, S
    Smolinski, M
    Wurst, M
    West, S
    Houdijk, WPM
    Quintel, M
    Borggrefe, M
    CRITICAL CARE MEDICINE, 2004, 32 (02) : 520 - 524
  • [29] The Distribution of Anti-factor Xa Activity Values, Prothrombin Time and Activated Partial Thromboplastin Time Assessed at Multiple Points in Patients on Edoxaban Therapy
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa R.
    Hori, Yasuhiko
    Kobayashi, Yoshio
    CIRCULATION, 2020, 142
  • [30] PLASMA PREKALLIKREIN, FACTOR-XII, ANTITHROMBIN-III, C-1-INHIBITOR AND ALPHA-2-MACROGLOBULIN IN CRITICALLY III PATIENTS WITH SUSPECTED DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
    LAMMLE, B
    TRAN, TH
    RITZ, R
    DUCKERT, F
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1984, 82 (04) : 396 - 404